Troluce Capital Advisors’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$218K	Buy	150,000 +66,242	+79%	+$96.1K	0.05%	18
2025 Q1	$116K	Buy	83,758 +30,844	+58%	+$42.6K	0.03%	16
2024 Q4	$161K	Hold	52,914	–	–	0.01%	15
2024 Q3	$264K	Sell	52,914 -39,918	-43%	-$199K	0.02%	42
2024 Q2	$543K	Buy	+92,832	New	+$543K	0.05%	34